Provider

Jennifer Goldsack, CEO of the Digital Medicine Society, outlines DiMe's new project focused on aging-in-place with healthcare technologies and reimbursing remote patient monitoring as federal and private insurers' coverage policies evolve.

Dr. Ronald Whelan, CEO of South Africa's Discovery Health, discusses how the insurer uses a shared-value model supported by wearables, data and rewards to incentivize healthier habits.

ACCESS is a decade-long initiative to expand tech-enabled care and outcome-based payments for Medicare patients with obesity, diabetes, chronic pain and depression.

Ciba Health collaborates with Canadian health benefits administrator Quikcard, and Octave Bioscience signs a partnership agreement with Quest Diagnostics.

OSF HealthCare's Brandi Clark says that, in 2026, insurers' payments for telemedicine and remote patient monitoring reimbursement will increasingly align with organizations’ value-based care maturity.

The partners are employing AI to identify undiagnosed and undertreated patients, support clinical trials and advance precision therapies.

For now, the Trump Administration is turning its focus to The Genesis Mission, a new federal artificial intelligence effort that it says is "comparable in urgency and ambition to the Manhattan Project."

Neurogen will integrate Tasso's needle-free blood collection devices into its home-based Alzheimer’s testing platform.

According to Barrett Loveless, infrastructure director at the PET Imaging Institute, EDR (endpoint detection and response) tools, combined with expert monitoring, have kept the institute breach-free for a decade.

The Elton John AIDS Foundation, one of the first financial backers of Zipline and an established partner of the company, made the announcement.